GENMAB AS SP.ADR/1/10DK 1 (GE91) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.051x

Based on the latest financial reports, GENMAB AS SP.ADR/1/10DK 1 (GE91) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€301.00 Million ≈ $351.90 Million USD) by net assets (€5.85 Billion ≈ $6.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GE91 market cap overview for the company's overall valuation and market capitalisation.

GENMAB AS SP.ADR/1/10DK 1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how GENMAB AS SP.ADR/1/10DK 1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GENMAB AS SP.ADR/1/10DK 1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GENMAB AS SP.ADR/1/10DK 1 ranked by their cash flow conversion efficiency. Explore earnings quality score of GENMAB AS SP.ADR/1/10DK 1 to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tech Mahindra Limited NSE:TECHM	0.105x
Chocoladefabriken Lindt & Spruengli AG N SW:LISN	0.135x
Lattice Semiconductor Corporation NASDAQ:LSCC	0.112x
Nippon Sanso Holdings Corp. NYSE:NPXYY	0.067x
Corebridge Financial Inc. NYSE:CRBG	-0.004x
Bosch Limited NSE:BOSCHLTD	0.071x
Pinnacle Financial Partners, Inc. NYSE:PNFP	0.006x
YPF Sociedad Anonima NYSE:YPF	0.000x

Annual Cash Flow Conversion Efficiency for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025. View GENMAB AS SP.ADR/1/10DK 1 stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€5.85 Billion ≈ $6.84 Billion	€1.19 Billion ≈ $1.39 Billion	0.203x	-4.21%
2024-12-31	€5.12 Billion ≈ $5.99 Billion	€1.08 Billion ≈ $1.27 Billion	0.212x	-9.30%
2023-12-31	€4.69 Billion ≈ $5.49 Billion	€1.10 Billion ≈ $1.28 Billion	0.233x	+62.82%
2022-12-31	€3.93 Billion ≈ $4.59 Billion	€563.05 Million ≈ $658.26 Million	0.143x	+42.85%
2021-12-31	€3.38 Billion ≈ $3.95 Billion	€339.18 Million ≈ $396.54 Million	0.100x	--

About GENMAB AS SP.ADR/1/10DK 1

F:GE91 Germany Biotechnology

Market Cap

$17.14 Billion

€14.66 Billion EUR

Market Cap Rank

#1627 Global

#353 in Germany

Share Price

€23.80

Change (1 day)

+3.48%

52-Week Range

€17.00 - €29.80

All Time High

€44.40